Challenges exist in ensuring deceased donor organs are allocated to individuals on the transplant recipient waitlist in a fair, equitable, cost-effective and transparent manner. In response to the ...

As employers and patients struggle with rising prescription drug costs and limited pricing transparency, several solutions have emerged to help lower expenses. One approach is the cost-plus model, ...

When a technology with revolutionary potential comes on the scene, it’s easy for companies to let enthusiasm outpace fiscal discipline. Bean counting can seem short-sighted in the face of exciting ...

Non-English generative AI models are far less accurate and useful than their English-based counterparts — sometimes dramatically so. Companies paying for them should know what they’re getting, and ...